When a doctor mentions a new treatment for depression, most people ask whether it works. Fewer ask where it happens, and that second question often decides whether you can go through with it.

What follows is a script for asking it: what to say, what to listen for, and how to state your preference without talking yourself out of care you might need. It is not medical advice and recommends no treatment.

Why the setting deserves its own question

We commissioned a poll that asked 443 Midwest adults, spread over ten states, to picture pursuing ketamine or esketamine therapy and name the setting they would choose. The answers were not what the convenience era predicts. The clinic in person drew 44 percent. Home telehealth took 22 percent and a start-at-the-clinic, move-home-later plan 23, and 11 percent did not mind. These are final figures.

People hold real preferences about this, but the setting is not always a matter of preference; for some treatments the approval itself fixes it. The script below helps you tell which is which.

Opening the subject

Raise it right after your doctor names an option:

"Before we go further, can you tell me where this would actually happen? Would I come to an office, go to a special clinic, or do it at home?"

It is a practical question most doctors welcome, because it shows you are thinking about follow-through.

If the answer is "at a certified site"

That is what you should hear if the treatment is esketamine, sold as Spravato. Regulators approved it for depression that earlier medicines failed to relieve, and only certified clinics receive it. You use the spray yourself while a provider watches, remain two hours or longer under observation, and hand the car keys to someone else until the following day. Brain Recovery Centers keeps a short guide to Spravato visits that walks through that sequence.

Follow-up questions:

"Where is the nearest certified site that takes my insurance? How long does a visit usually take? How often would I need to go at the start?"

"Since I cannot drive afterward, does the site require a specific person to pick me up, or can I use a rideshare?"

Distance matters more than people expect. In our survey, closeness to home made the top two provider factors for 43 percent of respondents; only insurance ranked higher.

If the answer is "at home"

If a prescriber offers ketamine to take at home, you are discussing something other than the approved spray: generic ketamine used off label, usually a lozenge or tablet prescribed via telehealth, with no clinician in the room during a session.

That does not make it wrong for everyone, but it does mean more questions:

"Is this the FDA-approved product, or is it ketamine used off-label? Who would be watching me during a session? What happens if I feel unwell partway through?"

"Does my insurance cover this version, or would I be paying out of pocket?"

That last question matters. For 59 percent of our respondents, FDA approval would clinch the decision or weigh heavily in it. If that is you, say so plainly.

If the answer is "some of both"

A clinic-first, home-later plan can mean very different things, so ask:

"Which part happens in the clinic and which part at home? Is the medication itself ever taken at home, or just the follow-up visits?"

With the approved spray, dosing stays in the certified setting; a hybrid might move therapy or check-ins to video, not the dose. Knowing that up front prevents a surprise.

Stating your own preference

If you have a preference, say it and say why:

"I would feel safer doing this somewhere with staff around. Is that possible for what you are suggesting?"

"Getting to a clinic every week would be hard for me because of work and distance. Are there options that involve fewer trips?"

Your doctor may say a preference cannot be met for a given treatment. That is still worth knowing, and it may lead to another option or a plan for making the trips work.

Bringing up cost in the same breath

Setting and payment are linked, so ask about both. Coverage made the shortlist of two for 85 percent of respondents, and 65 percent rated it a deciding or major factor.

"If we go with the clinic option, will your office help me check coverage and prior authorization before I schedule?"

Half of the people we asked would rather clear extra insurance hurdles than pay for a simpler start; 23 percent preferred paying, and 26 percent were unsure. Either choice is legitimate if you make it knowingly.

Asking about options that involve no drug at all

Some people care about the setting because they are wary of medication altogether. If that is you, ask:

"Is there anything drug-free that fits my situation, like TMS?"

In our survey, 64 percent put value on a drug-free option, while only about a quarter, 25 percent, had heard of TMS. Asking costs nothing.

A one-card summary to bring

Where would this happen: clinic, certified site, or home?
Is it the FDA-approved product or off-label?
Who watches me during and after?
How far, how long, how often?
What does my plan cover?
Is there a drug-free alternative for me?

This conversation belongs with your doctor. In our survey, a nudge from their own doctor was the top persuader, at 74 percent. Use that relationship to get specifics.

Suicidal thoughts should not wait for the next appointment. Use 988, by phone or text, to reach the Lifeline at any hour, for free and in confidence.

Methodology

This publisher paid for and commissioned Pollfish study 395586438, whose last day on the Pollfish consumer panel was June 23, 2026. The 443 respondents were Midwest adults between 18 and 64, spread across ten states, and only top-line results are reported here. Multi-select answers are shares of all respondents. Each figure has cleared final panel validation.

Ask your doctor where the treatment would actually happen